It began with a promise. More than 100 years ago, CSL was formed to save lives using the latest technologies. In the century since, CSL Behring has grown into a global biotechnology leader, driven by that same promise to save and improve lives. We offer the broadest range of quality plasma-derived and recombinant therapies in our industry. Our ability to innovate and deliver life-saving medicines for patients with unmet medical needs around the world has earned us a reputation for always putting patients first. We are CSL Behring and we are driven by our promise.
Read our Corporate Brochure or view our Fact Sheet.
Our head office for the Nordic Region is in Sweden and has representatives in Denmark, Finland, Norway, and Sweden. Our Danish representative is also contact person for Iceland and can be reached by phone or email as detailed below:
Mette Toft Jacobsen
Country Sales Manager
Dir tlf.: +45 24 48 56 85
Email: Click here
Disclosure reports for Iceland can be found on the Icelandic Association of the Pharmaceutical Industry's homepage Frumtök